Inogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Inogen (INGN). Shares have lost about 0.8% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Inogen due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.

How Have Estimates Been Moving Since Then?

It turns out, fresh estimates have trended downward during the past month.

VGM Scores

At this time, Inogen has an average Growth Score of C, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.

Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been broadly trending downward for the stock, and the magnitude of this revision indicates a downward shift. Notably, Inogen has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry Player

Inogen belongs to the Zacks Medical - Instruments industry. Another stock from the same industry, Mettler-Toledo (MTD), has gained 5.7% over the past month. More than a month has passed since the company reported results for the quarter ended March 2025.

Mettler-Toledo reported revenues of $883.74 million in the last reported quarter, representing a year-over-year change of -4.6%. EPS of $8.19 for the same period compares with $8.89 a year ago.

Mettler-Toledo is expected to post earnings of $9.57 per share for the current quarter, representing a year-over-year change of -0.8%. Over the last 30 days, the Zacks Consensus Estimate has changed 0%.

Mettler-Toledo has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of C.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research